Adare Pharma Solutions, a tech driven CDMO specializing in oral dosage forms, has announced expansions of its high potency ...

UK-based pharma manufacturer Ennogen has received a £30 million credit facility from Santander UK to support its ...

Pfizer's groundbreaking $3.5 million gene therapy for Hemophilia B just got FDA approval. Here’s what it means for patients ...

Bristol Myers Squibb partners with Repertoire Immune Medicines to develop innovative vaccines aimed at treating autoimmune ...

Almost half of all strategic alliances focused on RNA therapies over the last five years in the Asia-Pacific (APAC) region ...

The UK/Irish company SynOx Therapeutics plans to run a phase 3 trial of a potentially best-in-class antibody therapy for the ...

With equipment that promises to produce 10 times more therapies, the deal with Cellares is hoped to make BSM's CAR-T ...

After two major acquisitions, Biosynth is coming to CPHI North America ready to tell the industry about its enhanced ...

What is ADC specialist Piramal Pharma planning for the upcoming CPHI North America conference? We sat down with chief ...

CN Bio has raised $21 million in Series B financing to meet increasing demand for its organ-on-a-chip (OOC) solutions.

A recent Deloitte report revealed that 36% of healthcare product launches fell short of achieving 80% of their sales targets ...

Celularity, a biotech company specializing in placental-derived allogeneic cell therapies, will be showcasing data at the ...